Silexion Announces 1-for-24 Reverse Stock Split
Silexion Therapeutics announced a 1-for-24 reverse share split effective on November 11, 2026, to regain compliance with Nasdaq listing requirements. The split adjusts trading solely to the par value of $3.24 per share without fractional shares.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed